The Gross Margin of Yabao Pharmaceutical Group Co Ltd (600351.SS) is 51.56%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 51.56% |
| 2024-12-31 | 50.98% |
| 2023-12-31 | 57.50% |
| 2022-12-31 | 55.45% |
| 2021-12-31 | 60.66% |
| 2020-12-31 | 59.03% |
| 2019-12-31 | 62.99% |
| 2018-12-31 | 60.00% |
| 2017-12-31 | 56.37% |
| 2016-12-31 | 44.17% |